“慢研发”跑出“快增长” 医研共创如何稳扎稳打？

Core Insights - The skin is described as the body's first line of defense against external pathogens, emphasizing the importance of skin barrier repair and the activation of self-repair capabilities rather than merely supplementing deficiencies [2] - The trend of medical-research collaboration is becoming a strategic choice for cosmetic giants to build differentiated advantages, with companies like L'Oréal, Shiseido, and Estée Lauder investing in partnerships with medical institutions for research and product development [2] Group 1: Product Development and Market Strategy - Shanghai Jahwa and Ruijin Hospital have collaborated since 2003, leading to the launch of the first barrier repair product after 6 years of research and 1,386 clinical validations [3] - The pricing strategy for the new product aims to ensure affordability and long-term use, addressing the needs of patients who require ongoing skin care after clinical treatment [3] - The second-generation barrier repair cream is set to launch in early 2025, with projected sales exceeding 100 million yuan in the same year, indicating strong market potential [6] Group 2: Industry Trends and Research Collaboration - The establishment of the Shanghai Jahwa-Ruijin Guangci Skin Disease Charity Fund aims to assist impoverished skin disease patients while utilizing real cases and clinical data to enhance product research and development [4] - The industry is calling for more long-term players in the barrier repair segment, with a focus on creating stable products that can be used repeatedly without disrupting the skin's metabolic processes [6] - The emphasis is shifting from rapid market trends to addressing real clinical issues, as highlighted by experts who criticize the lack of scientific basis in many current cosmetic products [7] Group 3: Research Standards and Collaboration - Shanghai Jahwa has led the drafting and publication of the "Cosmetic Medical Research Cooperation Standards," promoting shared research methodologies to encourage deeper industry engagement [8] - The CARE principle, which stands for Clinical Insight, Research Empowerment, Barrier Repair Priority, and Evidence-Driven Standards, encapsulates the brand's approach to medical-research collaboration [8] - To date, over 5,046 clinical studies have been completed, with partnerships established with more than 40 top-tier hospitals and over 3,000 dermatology experts [8]